Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 26% ± 12% | |
fibroblast | 12 studies | 24% ± 10% | |
basal cell | 8 studies | 30% ± 12% | |
neuron | 7 studies | 33% ± 21% | |
epithelial cell | 7 studies | 35% ± 18% | |
endothelial cell | 7 studies | 25% ± 6% | |
glutamatergic neuron | 6 studies | 40% ± 22% | |
GABAergic neuron | 6 studies | 34% ± 15% | |
connective tissue cell | 5 studies | 27% ± 9% | |
smooth muscle cell | 5 studies | 21% ± 4% | |
club cell | 4 studies | 20% ± 4% | |
pancreatic A cell | 4 studies | 42% ± 13% | |
myofibroblast cell | 4 studies | 18% ± 3% | |
pericyte | 4 studies | 21% ± 7% | |
interneuron | 4 studies | 32% ± 17% | |
secretory cell | 3 studies | 28% ± 14% | |
type B pancreatic cell | 3 studies | 33% ± 3% | |
retinal ganglion cell | 3 studies | 81% ± 12% | |
enterocyte | 3 studies | 16% ± 1% | |
mesothelial cell | 3 studies | 34% ± 18% | |
CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 790.30 | 359 / 359 | 100% | 69.87 | 285 / 286 |
brain | 100% | 2158.49 | 2641 / 2642 | 100% | 102.50 | 702 / 705 |
ovary | 99% | 1034.02 | 179 / 180 | 100% | 92.40 | 430 / 430 |
bladder | 100% | 788.24 | 21 / 21 | 98% | 91.14 | 496 / 504 |
uterus | 99% | 1041.31 | 169 / 170 | 99% | 122.28 | 454 / 459 |
intestine | 100% | 871.64 | 965 / 966 | 98% | 76.36 | 517 / 527 |
breast | 99% | 758.66 | 453 / 459 | 99% | 117.75 | 1110 / 1118 |
pancreas | 99% | 864.33 | 325 / 328 | 99% | 77.60 | 176 / 178 |
liver | 99% | 1215.69 | 223 / 226 | 99% | 142.80 | 403 / 406 |
esophagus | 99% | 962.17 | 1437 / 1445 | 98% | 90.53 | 180 / 183 |
adrenal gland | 100% | 1782.42 | 258 / 258 | 97% | 119.48 | 224 / 230 |
prostate | 99% | 874.82 | 242 / 245 | 98% | 74.39 | 494 / 502 |
thymus | 99% | 772.22 | 646 / 653 | 98% | 58.64 | 594 / 605 |
kidney | 99% | 935.33 | 88 / 89 | 96% | 75.11 | 865 / 901 |
lung | 91% | 554.92 | 528 / 578 | 100% | 131.44 | 1155 / 1155 |
skin | 90% | 599.75 | 1637 / 1809 | 98% | 90.00 | 464 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.68 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 135.35 | 45 / 45 |
blood vessel | 100% | 1353.85 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 749.42 | 1189 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 423.68 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 79% | 346.57 | 680 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 29.02 | 61 / 80 |
peripheral blood | 21% | 201.03 | 191 / 929 | 0% | 0 | 0 / 0 |
muscle | 2% | 7.06 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0070453 | Biological process | regulation of heme biosynthetic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1901029 | Biological process | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM14A |
Protein name | Transmembrane protein 14A Alternative protein TMEM14A |
Synonyms | C6orf73 PTD011 |
Description | FUNCTION: Inhibits apoptosis via negative regulation of the mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. . |
Accessions | ENST00000211314.5 L0R8I9 Q9Y6G1 |